High concentrations of unconjugated bilirubin (UCB) have toxic effects. The aim of our study was to find a way to elevate UCB tolerance or inhibit its toxicity in neurocytes. It has been reported that cystatin C (CST3) concentrations have a significant positive correlation with total bilirubin (TB) levels and a negative correlation with albumin levels. In addition, CST3 can directly bind UCB, decrease human umbilical vein endothelial cells' permeability, improve blood-brain barrier integrity after ischemic brain injury in mice, and induce autophagy. We hypothesized that CST3 could increase the solubility of UCB, decrease permeability of neurocytes, induce autophagy of neurocytes, and alleviate bilirubin-induced damage. To verify our hypothesis, we measured TB and conjugated bilirubin levels, and the permeability and autophagy of neurocytes treated with UCB and CST3. Our findings suggest that CST3 can protect against UCB-induced damage in neurocytes and that autophagy played an important role in this process.
Keyphrases
- oxidative stress
- endothelial cells
- high glucose
- diabetic rats
- cell death
- brain injury
- blood brain barrier
- endoplasmic reticulum stress
- signaling pathway
- cerebral ischemia
- mycobacterium tuberculosis
- subarachnoid hemorrhage
- ischemia reperfusion injury
- adipose tissue
- type diabetes
- skeletal muscle
- insulin resistance
- oxide nanoparticles